Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Phio Pharmaceuticals Corp. - Common Stock (NQ:PHIO)

2.130 -0.050 (-2.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 107,986
Open 2.130
Bid (Size) 2.110 (18)
Ask (Size) 2.150 (5)
Prev. Close 2.180
Today's Range 2.064 - 2.200
52wk Range 0.9657 - 9.790
Shares Outstanding 5,726,750
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Clinical trial advances to anticipated final cohort for INSTASYL siRNA lead product candidate PH-7625th cohort patients now being treated in... 
Via Newsfile
Phio Posts Wider Loss in Fiscal Q2
Via The Motley Fool

Performance

YTD
+12.1%
+12.1%
1 Month
-2.3%
-2.3%
3 Month
-14.1%
-14.1%
6 Month
+56.6%
+56.6%
1 Year
-35.6%
-35.6%

More News

Read More
Phio Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Via Newsfile
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds
Via Newsfile
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Phio Pharmaceuticals Announces Pathology Results for Four of Five Patients in Fourth Cohort
Via Newsfile
Gapping stocks in Friday's session
Via Chartmill
Friday's pre-market session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Phio Pharmaceuticals Announces Agreement with U.S. Manufacturing Source for Drug Substance
Via Newsfile
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort
Via Newsfile
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Via Newsfile
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Which stocks are gapping on Thursday?
Via Chartmill
Sidoti Events, LLC's Virtual May Micro-Cap Conference
Via ACCESS Newswire
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference
Via Newsfile
Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
Via Newsfile
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Phio Pharmaceuticals Announces Positive Pathology Results in Third Cohort in INTASYL PH-762 Skin Cancer Clinical Trial
Via Newsfile
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Via Newsfile
Top movers in Wednesday's session
Via Chartmill
Top movers analysis in the middle of the day on 2025-04-23: top gainers and losers in today's session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
The market is filled with gapping stocks in Wednesday's session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is Phio Pharmaceuticals Corp. - Common Stock publicly traded?
Yes, Phio Pharmaceuticals Corp. - Common Stock is publicly traded.
What exchange does Phio Pharmaceuticals Corp. - Common Stock trade on?
Phio Pharmaceuticals Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Phio Pharmaceuticals Corp. - Common Stock?
The ticker symbol for Phio Pharmaceuticals Corp. - Common Stock is PHIO on the Nasdaq Stock Market
What is the current price of Phio Pharmaceuticals Corp. - Common Stock?
The current price of Phio Pharmaceuticals Corp. - Common Stock is 2.130
When was Phio Pharmaceuticals Corp. - Common Stock last traded?
The last trade of Phio Pharmaceuticals Corp. - Common Stock was at 09/15/25 04:00 PM ET
What is the market capitalization of Phio Pharmaceuticals Corp. - Common Stock?
The market capitalization of Phio Pharmaceuticals Corp. - Common Stock is 12.20M
How many shares of Phio Pharmaceuticals Corp. - Common Stock are outstanding?
Phio Pharmaceuticals Corp. - Common Stock has 12M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.